Effects of Graded Activity on Low Back Pain in Patients with Type 2 Diabetes

Effects of Graded Activity Protocol on Clinical and Psychosocial Attributes of Patients with Concomitant Low-Back pain and Type 2 Diabetes Mellitus

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201702001728564

Enrollment

Registered

2016-07-26

Start date

2013-02-04

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases Type 2 Diabetes and Low Back Pain

Interventions

Graded Activity Protocol for patients with type 2 diabetes

Graded Activity Protocol for patients without type 2 diabetes

Graded Activity and monitored daily physical activity for patients with type 2 diabetes

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Individuals diagnosed of T2DM with complaints of non-specific LBP of not less than 3 months duration were included in the study. Individuals with complaints of non-specific of not less than 3 months duration without any co-morbidity were eligible to participate as controls in this study. Individuals diagnosed with T2DM for not less than 1 year were eligible to participate in the study. Individuals who understood either of English or Yoruba language or both were eligible to participate in the study.

Exclusion criteria

Exclusion criteria: Individuals with morbidities beside T2DM (like uncontrolled hypertension, stroke and asthma) were excluded from the study. Patients who were on insulin therapy or who had used insulin in the previous 6 months were excluded from the study. Individuals who presented with additional disabling conditions such as blindness and amputations were excluded from the study. Patients with red flags suggestive of serious spinal pathology with signs and symptoms of nerve root compromise (with at least two of the following: dermatomal sensory loss, myotomal muscle weakness and reduced lower limb reflexes) were excluded from the study. Patients with severe peripheral neuropathy were excluded from the study.

Design outcomes

Primary

Measure	Time frame
Pain intensity, Static Abdominal Muscular Endurance, Static Back Extensors Endurance, LBP-related disability, pain self-efficacy belief, fear avoidance behaviour and back pain consequences belief;Pain Intensity,Static Abdominal Musculature Endurance, Static Back Extensors Endurance, Haemoglobin A1c, activity limitation, Pain Self-Efficacy,Fear Avoidance Behaviour, belief of consequence of back pain	—

Measure

Time frame

Pain intensity, Static Abdominal Muscular Endurance, Static Back Extensors Endurance, LBP-related disability, pain self-efficacy belief, fear avoidance behaviour and back pain consequences belief;Pain Intensity,Static Abdominal Musculature Endurance, Static Back Extensors Endurance, Haemoglobin A1c, activity limitation, Pain Self-Efficacy,Fear Avoidance Behaviour, belief of consequence of back pain

—

Secondary

Measure	Time frame
Fasting Blood sugar, glycosylated haemoglobin A1C	—

Countries

Nigeria

Contacts

Public ContactAde;Opeyemi Adeniyi;Idowu

Senior Lecturer/ University of Ibadan, Nigeria;Lecturer/ University of Benin, Benin-City, Nigeria

adefataiadeniyi@yahoo.co.uk;opeyemi.idowu@uniben.edu+2348057325888;+2347036872825

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026